RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Roivant Sciences Stock

Roivant Sciences ROCE 2025

Roivant Sciences ROCE

-0.24

Ticker

ROIV

ISIN

BMG762791017

WKN

A3C4MS

In 2025, Roivant Sciences's return on capital employed (ROCE) was -0.24, a -76.6% increase from the -1.02 ROCE in the previous year.

Roivant Sciences Aktienanalyse

What does Roivant Sciences do?

Roivant Sciences Ltd is a biopharmaceutical company based in Basel, Switzerland. It was founded in 2014 by Vivek Ramaswamy, a former hedge fund manager. The company's idea was to develop "orphan molecules," which are drug compounds that have not been further developed by large pharmaceutical companies for various reasons. Roivant Sciences' business model is based on identifying therapy areas with high unmet medical needs. It then collaborates with academic institutions and other partners to search for orphan molecules that could be potentially interesting for these therapy areas. The molecules are further developed in the company's internal research and development laboratories. Roivant Sciences has established seven different subsidiary companies through its innovative approach to drug development and acquisition of other companies. Some of the most well-known subsidiaries include Axovant Sciences, Dermavant Sciences, Enzyvant Therapeutics, and Myovant Sciences. Each subsidiary of Roivant Sciences focuses on specific therapy areas. For example, Axovant Sciences focuses on developing therapies for neurological diseases such as Parkinson's and Alzheimer's, while Dermavant Sciences focuses on dermatology and Enzyvant Therapeutics concentrates on rare genetic diseases. Roivant Sciences has also raised a considerable amount of capital to finance its various companies. In 2017, the company raised $1.1 billion, expanding its presence in the global healthcare market. Products developed by Roivant Sciences' subsidiaries include Axovant's Nelotanserin, a potential medication for hallucinations and nightmares in Parkinson's patients, as well as Myovant's Leuprolide, a medication for treating prostate cancer. The company also has a partnership with Dartmouth College to advance research and development in neuroscience. The partnership aims to identify "specific molecular targets" for developing treatments for neurodegenerative diseases. In summary, Roivant Sciences Ltd is an innovative biopharmaceutical company that develops orphan molecules and specializes in various therapy areas. Its subsidiaries develop products for a range of diseases, from Alzheimer's to prostate cancer and rare genetic disorders. The company has raised a significant amount of capital to finance its operations and collaborates with academic institutions to advance its research and development. Roivant Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Roivant Sciences's Return on Capital Employed (ROCE)

Roivant Sciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Roivant Sciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Roivant Sciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Roivant Sciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Roivant Sciences stock

What is the ROCE (Return on Capital Employed) of Roivant Sciences this year?

The ROCE of Roivant Sciences is -0.24 undefined this year.

How has the ROCE (Return on Capital Employed) of Roivant Sciences developed compared to the previous year?

The ROCE of Roivant Sciences has increased by -76.6% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Roivant Sciences?

A high Return on Capital Employed (ROCE) indicates that Roivant Sciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Roivant Sciences?

A low ROCE (Return on Capital Employed) can indicate that Roivant Sciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Roivant Sciences impact the company?

An increase in the ROCE of Roivant Sciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Roivant Sciences affect the company?

A decrease in ROCE of Roivant Sciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Roivant Sciences?

Some factors that can affect Roivant Sciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Roivant Sciences so important for investors?

The ROCE of Roivant Sciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Roivant Sciences take to improve the ROCE?

To improve the ROCE, Roivant Sciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Roivant Sciences pay?

Over the past 12 months, Roivant Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Roivant Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Roivant Sciences?

The current dividend yield of Roivant Sciences is .

When does Roivant Sciences pay dividends?

Roivant Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Roivant Sciences?

Roivant Sciences paid dividends every year for the past 0 years.

What is the dividend of Roivant Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Roivant Sciences located?

Roivant Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Roivant Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Roivant Sciences from 8/22/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/22/2025.

When did Roivant Sciences pay the last dividend?

The last dividend was paid out on 8/22/2025.

What was the dividend of Roivant Sciences in the year 2024?

In the year 2024, Roivant Sciences distributed 0 USD as dividends.

In which currency does Roivant Sciences pay out the dividend?

The dividends of Roivant Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Roivant Sciences

Our stock analysis for Roivant Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Roivant Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.